SAVE THE DATE!Social Media CoordinatorJun 18, 20181 min readOCN Certification Review CourseNovember 3rd, 2018More details to come...Come join BONS at Dana-Farber Cancer Institute for our next OCN Certification Review Course
CAR-Therapy Adverse Reaction Identification and Management Considerations ~ Thursday, June 12th @ Davio's
NEW EVENT: Exploring the Role of NUBEQA (darolutamide) in mHSPC in Combination with Docetaxel and in nmCRPC PP-NUM-US-3389-1
Comentarios